Scientists call on US to allow research on pot meds for pets

  • Dec. 7, 2017 6:55 a.m.
Scientists call on US to allow research on pot meds for pets

BEND, Ore. — Dr. Byron Maas surveys a supply of marijuana products for dogs that lines a shelf in his veterinary clinic. They’re selling well.

“The ‘Up and Moving’ is for joints and for pain,” he explains. “The ‘Calm and Quiet’ is for real anxious dogs, to take away that anxiety.”

People anxious to relieve suffering in their pets are increasingly turning to oils and powders that contain CBDs, a non-psychoactive component of marijuana. But there’s little data on whether they work, or if they have harmful side effects.

That’s because Washington has been standing in the way of clinical trials, veterinarians and researchers say. Now, a push is underway to have barriers removed, so both pets and people can benefit.

Those barriers have had more than just a chilling effect.

When the federal Drug Enforcement Administration announced last year that even marijuana extracts with CBD and little or no THC – marijuana’s intoxicating component – are an illegal Schedule 1 drug, the University of Pennsylvania halted its clinical trials. Colorado State University is pushing ahead.

The U.S. Food and Drug Administration has warned companies that sell marijuana products online and via pet shops and animal hospitals that they’re violating laws by offering “unapproved new animal drugs.” The FDA threatened legal action.

But, seeing potential benefits of CBDs, the American Veterinary Medical Association’s policy-making body said last summer it wants the DEA to declassify marijuana as a Schedule 1 drug “to facilitate research opportunities for veterinary and human medical uses.” It asked the board of the national veterinarians’ organization to investigate working with other stakeholders toward that goal. The board is awaiting a recommendation from two group councils.

“The concern our membership has is worry about people extrapolating their own dosages, looking to medicate their pets outside the realm of the medical professional,” Board Chairman Michael Whitehair said in a telephone interview. “This is an important reason for us to continue the research.”

Utah Sen. Orrin Hatch, a conservative Republican, became an unlikely champion of this push when he introduced a bill in September that would open the path for more clinical research. While Hatch said he opposes recreational marijuana use, he wants marijuana-based drugs, regulated by the FDA, produced for people with disorders.

“We lack the science to support use of medical marijuana products like CBD oils, not because researchers are unwilling to do the work, but because of bureaucratic red tape and over-regulation,” Hatch said.

Dawn Boothe, of Auburn University’s College of Veterinary Medicine, is waiting for federal approval to begin a study of marijuana’s effects on dogs with epilepsy. The classification of marijuana products containing CBD as a Schedule 1 drug, the same category as heroin and LSD, creates a “major, major, major, terrible roadblock” for researchers, Boothe said in a phone interview.

Researchers at the University of Pennsylvania School of Veterinary Medicine were studying CBDs’ effects on dogs with osteoarthritis and pruritis, or itchiness, until the DEA released its policy statement.

“The ambiguity in this process has really brought us to a screeching halt,” said Michael DiGregorio, director of the university’s clinical trials centre. “It is research that needs to be done, because there are a lot of CBD products out there.”

When it clarified that marijuana CBD extracts are Schedule 1 drugs, the DEA said it was assigning a code number to those substances to better track them and to comply with international drug control treaties.

DiGregorio complained that researchers seeking federal approval to study CBD products are told to provide certain data, but that data isn’t normally available until the study is done.

“If you don’t have the data, you can’t get the registration to do the work,” he said.

On a recent morning, Maas took a break from seeing four-legged patients in the Bend Veterinary Clinic. A stethoscope dangling from his neck over green scrubs, Maas said his clients have reported CBDs help relieve pain, arthritis, anxiety, loss of appetite, epilepsy and inflammation in their pets.

“Unfortunately there’s not a lot of research out there, especially on animals, on CBD compounds,” Maas said. “The research is really necessary to help us understand how to actually use these compounds on our pets.”

Veterinarian Janet Ladyga of the Blue Sky Veterinary Clinic, also in Bend, said she doesn’t recommend marijuana products because of the unknowns.

“We don’t have a lot of evidence right now, so we don’t know the toxicity or the safety profile … and we don’t have any good evidence to show either if it’s safe or efficacious,” she said.

The study at Colorado State University aims to provide some data. The roughly two dozen dogs in the arthritis study and the 30 in the epilepsy tests are given either CBD oil or a placebo. For the arthritis study, activity monitors are attached to the animals’ collars, to determine if they’re more mobile when they’re taking CBD.

Principal investigator Stephanie McGrath said she hopes the results will be a stepping stone for longer and more diverse studies, and that they provide useful information for human medicine.

“Every medication we’re taking has been given to a dog first,” the University of Pennsylvania’s DiGregorio noted.

Meanwhile, Boothe said she had everything ready to start her study in January, and was waiting for a green light from federal officials.

“I don’t know what’s taking so long,” she said.

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

Alberta Chief Medical Officer of Health Dr. Deena Hinshaw said on Thursday that the province reported the first case of the B.1.617 variant. (Photography by Chris Schwarz/Government of Alberta)
Red Deer nears record number of active COVID-19 cases

Alberta reports 1,857 new cases of COVID-19, 1,326 new variants

After considerable consultation with student representatives, Red Deer College has
made the difficult decision to increase tuition and fees for the 2021/2022 academic year. (Contributed photo)
Red Deer College to celebrate grads virtually in June

Graduates of Red Deer College won’t get an in-person graduation ceremony this… Continue reading

The Bowden Institution medium security facility is dealing with a COVID-19 outbreak. THE CANADIAN PRESS/Jeff McIntosh
Central Alberta Addiction centre faces COVID-19 outbreak

18 test positive at iRecover Treatment Centre in Tees

A cleaner goes into Red Deer’s Canada Post sorting facility near 67th Street and Taylor Drive on Thursday morning. Photo by PAUL COWLEY/Advocate staff
Employee tests positive for COVID-19 at Red Deer Canada Post mail sorting facility

Canada Post has confirmed an employee at the Red Deer mail processing… Continue reading

Two people (not in photo) are facing charges following a Sept. 20, 2020 anti-racism rally in Red Deer.
Advocate file photo
Woman charged in Red Deer anti-racism rally going to trial

Calgary woman facing a charge of assault with a weapon in connection with Sept. 20, 2020 rally

Curtis Labelle (second from left) and his band are planning a cross-Canada tour in 2022. Meanwhile, Labelle is continuing to host his weekly livestreamed talk show, Chattin 88. (Contributed photo).
Red Deer rock pianist takes on a talk show role

Curtis Labelle’s Chattin 88 gets views from around the globe

SickKids surgeons give baby another shot at life after removing nearly 3-pound tumour

SickKids surgeons give baby another shot at life after removing nearly 3-pound tumour

A COVID-19 patient wearing oxygen mask waits inside a vehicle to be attended and admitted in a dedicated COVID-19 government hospital in Ahmedabad, India, Thursday, April 22, 2021. India reported a global record of more than 314,000 new infections Thursday as a grim coronavirus surge in the world's second-most populous country sends more and more sick people into a fragile health care system critically short of hospital beds and oxygen. THE CANADIAN PRESS/AP /Ajit Solanki
COVID-19 variant of interest vs. variant of concern: What does it mean?

COVID-19 variant of interest vs. variant of concern: What does it mean?

File photo
Expert says Saskatchewan should consider more targeted vaccine plan as variants surge

SASKATOON — Nazeem Muhajarine says he feels a sense of relief after… Continue reading

Canadian Prime Minister Justin Trudeau and United States President Joe Biden smile as they say farewell following a virtual joint statement in Ottawa, Tuesday, February 23, 2021. THE CANADIAN PRESS/Adrian Wyld
Trudeau pledges to cut emissions by 40% to 45% by 2030, short of U.S. goal

OTTAWA — Prime Minister Justin Trudeau is promising Canada will slash its… Continue reading

Finance Minister Chrystia Freeland holds a press conference in Ottawa on Tuesday, April 20, 2021. THE CANADIAN PRESS/Sean Kilpatrick
More supply needed to ease housing price crunch, but always more to do, Freeland says

OTTAWA — Finance Minister Chrystia Freeland says the country needs a boost… Continue reading

Smoke pours from the stacks at the Portlands Energy Centre in Toronto on Thursday January 15, 2009. THE CANADIAN PRESS/Frank Gunn
Risk experts say climate change to take big chunk of Canadian economy by 2050

One of the world’s largest insurers says Canadians will be more than… Continue reading

A Blanding’s turtle (Gabrielle Fortin/Contributed)
Earth Day: Finding hope in an old sweater

During the pandemic, many of us have spent several months at home.… Continue reading

Education Minister Adriana LaGrange says 1.7 million reusable masks have been ordered at a cost of $4.2 million.” (Advocate file photo).
Alberta teachers and education minister swap accusations of politicizing curriculum

EDMONTON — Education Minister Adriana LaGrange says the group representing Alberta teachers… Continue reading

Most Read